TRANSMEDI SA has a total of 27 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are TARGETED MOLECULAR DIAGNOSTICS LLC, CARIS LIFE SCIENCES LUXEMBOURG HOLDINGS S A R L and DEVARAJAN PRASAD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | Brazil | 2 | |
#5 | Hong Kong | 2 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | China | 1 | |
#9 | EAPO (Eurasian Patent Organization) | 1 | |
#10 | Mexico | 1 | |
#11 | New Zealand | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Peptides | |
#3 | Measuring microorganism processes | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Bihain Bernard | 23 |
#2 | Brulliard Marie | 16 |
#3 | Ogier Virginie | 12 |
#4 | Bernard Bihain | 2 |
#5 | Marie Brulliard | 1 |
#6 | Virginie Ogier | 1 |
Publication | Filing date | Title |
---|---|---|
EP2080812A1 | Compositions and methods of detecting post-stop peptides | |
EP2071334A1 | Compositions and methods of detecting TIABS | |
EP1887088A1 | Transcription infidelity, detection and uses thereof |